Fighting malaria

Working with Comic Relief to fight malaria

The challenge of malnutrition in remote parts of the world like the Pacific has both a human and economic cost – and can be devastating not only for individuals but at a macro-level too.

Pneumonia is a preventable and treatable disease. Yet it is still one of the world’s leading causes of death in children under five years old: in 2015 almost one million children under five lost their lives due to this deadly disease. 12 November 2016 is World Pneumonia Day. On this day we will join others in raising awareness of the disease and taking action to tackle it.

28 September is World Rabies Day, when organisations across the globe, all with the common goal of eliminating human deaths from rabies by 2030, work together to raise awareness of this ‘neglected tropical disease’ under the theme ‘Educate, Vaccinate, Eliminate’.

Humanitarian crises are becoming more frequent, more widespread and more complex. It’s clear that a new approach is needed.

How our partnership with Save the Children is boosting healthcare innovation that supports vulnerable children.

Mckline is a special little boy. Almost two years old, he lives in Kenya with his parents Catherine and Fredrick. They are already saving for his education and have ambitions for him to be an engineer one day.

Since 2009, we have been working with Pro Mujer, helping women like Rosa lift themselves and their families out of poverty, and giving them access to high-quality, low-cost healthcare, often for the first time.

Dr Joe Cohen recalls his experiences of being part of the team to develop what could be the world’s first vaccine against malaria

Find out how our scientists have adapted an ingredient from a GSK mouthwash into a potentially life-saving gel for newborns in developing countries

According to the World Health Organization, only clean drinking water rivals vaccination in its ability to save lives.

Dr Kimberly Smith, vice president of medical strategy at ViiV Healthcare, shares her experiences of a career spent working to find a cure for the disease.

Jennifer Fear, CEO of Step Forward, describes how she and her charity benefited from winning a GSK IMPACT Award.

Scientist Lori Gavrin has first-hand experience of why we need to find new ways to help protect mothers and their newborn babies

See how malaria still leaves a devastating toll on communities and economies.

GSK has teamed up with Comic Relief to improve the lives of millions of people in Africa and Asia. Engineer and GSK executive Andy Wright explains.

We interview Christine McNab, curator of The Art of Saving a Life.

A blank canvas, Unformed clay. An empty petri dish.

Angela Muriuki finds that combating the high death rates in mothers and newborns in parts of Kenya involves knowledge of the culture of the people involved and the practical problems they face accessing healthcare.

What happened when GSK committed to reinvest 20% of its profits from the least developed countries back into those nations’ healthcare systems?

By the time the second hand on your wristwatch has circled its dial, a child in Africa will have died of malaria.

Almost everyone in Tanzania is at risk of malaria. The mosquito-borne disease is responsible for more than 10% of deaths among children under five in this East African country.

The combination of increased funding, resources and education to fight malaria have contributed to a reduction in deaths from this mosquito-borne disease.

Read how Robbie worked on the ground to fight Ebola.

GSK responded to the crisis by contributing humanitarian support and accelerating the development of an investigational Ebola vaccine.

We are determined to use our resources, knowledge and expertise to help improve access to immunisation.

‘Thermostability’ - it may sound very technical and complicated, but really it’s all about fridges.

GSK’s Jon Pender explains why working in partnership was key to addressing the pace of the Ebola outbreak in 2014.

The Ebola crisis of the past 14 months is by far the worst outbreak of the disease the world has ever seen.

Learn how we are advancing the development of our GSK/NIH Ebola vaccine candidate.

The Ebola crisis has been an unusual and rapidly changing situation. Find out how we are responding.

GSK's on-going efforts to strengthen healthcare infrastructure in the most affected countries.

Find out more about malaria and the life cycle of the parasites that cause it.

As a community health worker in Liberia – communities rely on people like Christopher for essential healthcare.

In a critical year in the fight against malaria, it will be community health workers and mothers themselves who play a vital role in helping to defeat the disease in Africa

Helping midwives like Mary develop their skills and ensure more women give birth safely in Africa.

The first 48 hours of life can be critical for a newborn baby. Infections like pneumonia, contracted during a baby’s first two days, can prove fatal.

Tijana Duric looks after the supply planning for albendazole in our neglected tropical diseases unit.

Fatiha describes her experience of polio and why she wanted to work for GSK.

When extracted and purified, a compound from the soap bark tree can be mixed with other ingredients to create an ‘adjuvant’, turbocharging the body's immune defences.

Our VP of east Africa and government affairs, Allan Pamba, explains his desire to improve the health of people in Africa.

Peter Albert couldn’t have known how instrumental his expertise would be in helping fight the Ebola outbreak.

Find out how we are breeding 2,000 mosquitoes every week in the search for anti-malarial medicines.

Back to top